Mayzent
NICE changes its mind on Novartis’ progressive MS drug Mayzent
Phil Taylor
Mayzent, multiple sclerosis, neurology, NICE, Novartis, UK
0 Comment
X
NICE changes its mind on Novartis’ progressive MS drug Mayzent
https://pharmaphorum.com/news/nice-changes-its-mind-on-novartis-progressive-ms-drug-mayzent/
Market Access/ News/ News/ News/ Patients/ Top stories
NICE says no to Novartis’ Mayzent in secondary progressive MS
Phil Taylor
Mayzent, multiple sclerosis, neurology, NICE, Novartis
0 Comment
X
NICE says no to Novartis’ Mayzent in secondary progressive MS
https://pharmaphorum.com/news/nice-says-no-to-novartis-mayzent-in-secondary-progressive-ms/
Novartis’ Mayzent, Roche’s Polivy head latest crop of CHMP approvals
Phil Taylor
Jazz Pharmaceuticals, Mayzent, Novartis, Polivy, Rigel Pharmaceuticals, Roche
0 Comment
X
Novartis’ Mayzent, Roche’s Polivy head latest crop of CHMP approvals
https://pharmaphorum.com/news/novartis-mayzent-roches-polivy-head-latest-crop-of-chmp-approvals/